Skip to main content
Hit enter to search or ESC to close
Close Search
RIS RxRIS Rx
Menu
  • Our Platform
  • Insights
  • Our Story
  • Get My GTN Assessment

    Stephen Hom

    Co-founder & COO
    Stephen Hom

    Stephen Hom

    Co-founder & COO

    Stephen serves as Chief Operating Officer of RIS Rx, which he co-founded in 2020. Stephen manages all aspects of operations in RIS Rx's patient affordability and gross-to-net (GTN) revenue protection solutions for pharma manufacturers, routinely combining his deep knowledge as a frontline pharmacist with scalable tech-enabled workflows. He earned his PharmD from Loma Linda University.

    Insights
    Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.
    Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.

    April 13, 2026

    Stephen Hom
    Stephen Hom Co-founder & COO
    AFP-based leakageGTN Insights
    What You Need to Know About the $90B Leakage Problem
    What You Need to Know About the $90B Leakage Problem

    April 1, 2026

    Stephen Hom
    Stephen Hom Co-founder & COO
    GTN Insights
    Closing the Affordability Gap in Real Time
    Closing the Affordability Gap in Real Time

    November 25, 2025

    Stephen Hom
    Stephen Hom Co-founder & COO
    Our Story

    Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.

    "*" indicates required fields

    Consent*
    GTN areas I‘d like to explore:
    • Our Platform
    • Insights
    • Our Story
    • Contact
    • Careers
    • Press
    Get My GTN Assessment

    RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.

    • Sitemap
    • Terms of Use
    • Privacy Policy
    • Cookie Settings
    • Do Not Sell My Personal Information
    Close Menu
    • Our Platform
    • Insights
    • Our Story
    • Get Assessment

    RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.